Increased immune gene expression and immune cell infiltration in high-grade astrocytoma distinguish long-term from short-term survivors

Journal of Immunology

Volumn 189, Issue 4, 2012, Pages 1920-1927

  Donson, Andrew M ^a,b   Birks, Diane K ^b,c   Schittone, Stephanie A ^a,b   Kleinschmidt DeMasters, Bette K ^c   Sun, Derrick Y ^c   Hemenway, Molly F ^a,b   Handler, Michael H ^b,c   Waziri, Allen E ^c   Wang, Michael ^a,b   Foreman, Nicholas K ^a,b,c  

^a Children's Hospital Colorado   (United States)

^b CHILDREN S HOSPITAL COLORADO   (United States)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AIF1 GENE; ARTICLE; ASTROCYTOMA; B LYMPHOCYTE; BONE MARROW CELL; CANCER SURVIVOR; CANCER TISSUE; CD3D GENE; CD3E GENE; CD3G GENE; CD68 GENE; CD86 GENE; CD8B GENE; CELL INFILTRATION; CHILD; CIITA GENE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; GENE; GENE EXPRESSION; GLIOBLASTOMA; HIGH GRADE ASTROCYTOMA; HISTOLOGY; HLA DOA GENE; HLA DQB2 GENE; HLA DRB1 GENE; HLA DRB6 GENE; HUMAN; HUMAN TISSUE; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; KARNOFSKY PERFORMANCE STATUS; MICROARRAY ANALYSIS; MONOCYTE; NATURAL KILLER CELL; NOD2 GENE; NUCLEOTIDE SEQUENCE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; SCHOOL CHILD; TRAC GENE; TRAT1 GENE; VAV1 GENE; ZAP70 GENE;

ASTROCYTOMA; BRAIN NEOPLASMS; GENE EXPRESSION PROFILING; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; KARNOFSKY PERFORMANCE STATUS; LYMPHOCYTES, TUMOR-INFILTRATING; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SURVIVORS;

EID: 84864822223     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1103373     Document Type: Article

References (42)

1. Stupp, R., W. P. Mason, M. J. van den Bent, M. Weller, B. Fisher, M. J. Taphoorn, K. Belanger, A. A. Brandes, C. Marosi, U. Bogdahn, et al European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group. 2005. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N. Engl. J. Med. 352: 987-996. (Pubitemid 40349501)
2. Prados, M. D., C. Scott, W. J. Curran, Jr., D. F. Nelson, S. Leibel, and S. Kramer. 1999. Procarbazine, lomustine, and vincristine (PCV) chemotherapy for anaplastic astrocytoma: A retrospective review of radiation therapy oncology group protocols comparing survival with carmustine or PCV adjuvant chemotherapy. J. Clin. Oncol. 17: 3389-3395. (Pubitemid 29517905)
3. Curran, W. J., Jr., C. B. Scott, J. Horton, J. S. Nelson, A. S. Weinstein, A. J. Fischbach, C. H. Chang, M. Rotman, S. O. Asbell, R. E. Krisch, et al. 1993. Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. J. Natl. Cancer Inst. 85: 704-710. (Pubitemid 23133591)
4. Hegi, M. E., A. C. Diserens, T. Gorlia, M. F. Hamou, N. de Tribolet, M. Weller, J. M. Kros, J. A. Hainfellner, W. Mason, L. Mariani, et al. 2005. MGMT gene silencing and benefit from temozolomide in glioblastoma. N. Engl. J. Med. 352: 997-1003. (Pubitemid 40349502)
5. Yan, H., D. W. Parsons, G. Jin, R. McLendon, B. A. Rasheed, W. Yuan, I. Kos, I. Batinic-Haberle, S. Jones, G. J. Riggins, et al. 2009. IDH1 and IDH2 mutations in gliomas. N. Engl. J. Med. 360: 765-773.
6. Rich, J. N., C. Hans, B. Jones, E. S. Iversen, R. E. McLendon, B. K. Rasheed, A. Dobra, H. K. Dressman, D. D. Bigner, J. R. Nevins, and M. West. 2005. Gene expression profiling and genetic markers in glioblastoma survival. Cancer Res. 65: 4051-4058. (Pubitemid 40775641)
7. Liang, Y., M. Diehn, N. Watson, A. W. Bollen, K. D. Aldape, M. K. Nicholas, K. R. Lamborn, M. S. Berger, D. Botstein, P. O. Brown, and M. A. Israel. 2005. Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme. Proc. Natl. Acad. Sci. USA 102: 5814-5819. (Pubitemid 40559642)
8. Serão, N. V., K. R. Delfino, B. R. Southey, J. E. Beever, and S. L. Rodriguez-Zas. 2011. Cell cycle and aging, morphogenesis, and response to stimuli genes are individualized biomarkers of glioblastoma progression and survival. BMC Med. Genomics 4: 49.
9. Zhang, J., B. Liu, X. Jiang, H. Zhao, M. Fan, Z. Fan, J. J. Lee, T. Jiang, T. Jiang, and S. W. Song. 2009. A systems biology-based gene expression classifier of glioblastoma predicts survival with solid tumors. PLoS ONE 4: e6274.
10. Phillips, H. S., S. Kharbanda, R. Chen, W. F. Forrest, R. H. Soriano, T. D. Wu, A. Misra, J. M. Nigro, H. Colman, L. Soroceanu, et al. 2006. Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 9: 157-173. (Pubitemid 43357943)
11. McLendon, R. E., O. Wiestler, J. M. Kros, A. Korshunov, and H. K. Ng. 2007. Ependymoma. In Pathology of Tumours of the Nervous System. World Health Organization Classification of Brain Tumors. W. W. Cavanee and P. Kleihues, eds. International Agency for Research on Cancer, Lyon, France, p. 74-78.
12. Wu, Z., I. R. Gentleman, R. Martinez, F. Murillo, and F. Spencer. 2004. A model-based background adjustment for oligonucleotide expression arrays. J. Am. Stat. Assoc. 99: 909-917. (Pubitemid 39665934)
13. Edgar, R., M. Domrachev, and A. E. Lash. 2002. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 30: 207-210. (Pubitemid 34679544)
14. Dennis, G., Jr., B. T. Sherman, D. A. Hosack, J. Yang, W. Gao, H. C. Lane, and R. A. Lempicki. 2003. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol. 4: 3.
15. Mootha, V. K., C. M. Lindgren, K. F. Eriksson, A. Subramanian, S. Sihag, J. Lehar, P. Puigserver, E. Carlsson, M. Ridderstråle, E. Laurila, et al. 2003. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet. 34: 267-273. (Pubitemid 36792858)
16. Ashburner, M., C. A. Ball, J. A. Blake, D. Botstein, H. Butler, J. M. Cherry, A. P. Davis, K. Dolinski, S. S. Dwight, J. T. Eppig, et al The Gene Ontology Consortium. 2000. Gene ontology: tool for the unification of biology. Nat. Genet. 25: 25-29. (Pubitemid 30257031)
17. Wu, C., C. Orozco, J. Boyer, M. Leglise, J. Goodale, S. Batalov, C. L. Hodge, J. Haase, J. Janes, J. W. Huss, III, and A. I. Su. 2009. BioGPS: an extensible and customizable portal for querying and organizing gene annotation resources. Genome Biol. 10: R130.
18. Yamada, M., K. Ohsawa, Y. Imai, S. Kohsaka, and S. Kamitori. 2006. X-ray structures of the microglia/macrophage-specific protein Iba1 from human and mouse demonstrate novel molecular conformation change induced by calcium binding. J. Mol. Biol. 364: 449-457. (Pubitemid 44715941)
19. Donson, A. M., D. K. Birks, V. N. Barton, Q. Wei, B. K. Kleinschmidt-Demasters, M. H. Handler, A. E. Waziri, M. Wang, and N. K. Foreman. 2009. Immune gene and cell enrichment is associated with a good prognosis in ependymoma. J. Immunol. 183: 7428-7440.
20. Marko, N. F., S. A. Toms, G. H. Barnett, and R. Weil. 2008. Genomic expression patterns distinguish long-term from short-term glioblastoma survivors: a preliminary feasibility study. Genomics 91: 395-406.
21. Swann, J. B., and M. J. Smyth. 2007. Immune surveillance of tumors. J. Clin. Invest. 117: 1137-1146. (Pubitemid 46718398)
22. Waziri, A., B. Killory, A. T. Ogden, III, P. Canoll, R. C. Anderson, S. C. Kent, D. E. Anderson, and J. N. Bruce. 2008. Preferential in situ CD4+CD56+ T cell activation and expansion within human glioblastoma. J. Immunol. 180: 7673-7680.
23. Monney, L., C. A. Sabatos, J. L. Gaglia, A. Ryu, H. Waldner, T. Chernova, S. Manning, E. A. Greenfield, A. J. Coyle, R. A. Sobel, et al. 2002. Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease. Nature 415: 536-541. (Pubitemid 34130609)
24. Filén, J. J., S. Filén, R. Moulder, S. Tuomela, H. Ahlfors, A. West, P. Kouvonen, S. Kantola, M. Björkman, M. Katajamaa, et al. 2009. Quantitative proteomics reveals GIMAP family proteins 1 and 4 to be differentially regulated during human T helper cell differentiation. Mol. Cell. Proteomics 8: 32-44.
25. Nishikomori, R., T. Usui, C. Y. Wu, A. Morinobu, J. J. O'Shea, and W. Strober. 2002. Activated STAT4 has an essential role in Th1 differentiation and proliferation that is independent of its role in the maintenance of IL-12R beta 2 chain expression and signaling. J. Immunol. 169: 4388-4398. (Pubitemid 35178213)
26. Galon, J., A. Costes, F. Sanchez-Cabo, A. Kirilovsky, B. Mlecnik, C. Lagorce-Pagès, M. Tosolini, M. Camus, A. Berger, P.Wind, et al. 2006. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 313: 1960-1964. (Pubitemid 44498003)
27. Brooks, W. H., W. R. Markesbery, G. D. Gupta, and T. L. Roszman. 1978. Relationship of lymphocyte invasion and survival of brain tumor patients. Ann. Neurol. 4: 219-224. (Pubitemid 8389815)
28. Palma, L., N. Di Lorenzo, and B. Guidetti. 1978. Lymphocytic infiltrates in primary glioblastomas and recidivous gliomas. Incidence, fate, and relevance to prognosis in 228 operated cases. J. Neurosurg. 49: 854-861. (Pubitemid 9062914)
29. Böker, D. K., R. Kalff, F. Gullotta, S. Weekes-Seifert, and U. Möhrer. 1984. Mononuclear infiltrates in human intracranial tumors as a prognostic factor. Influence of preoperative steroid treatment. I. Glioblastoma. Clin. Neuropathol. 3: 143-147.
30. Schiffer, D., D. Cavicchioli, M. T. Giordana, L. Palmucci, and A. Piazza. 1979. Analysis of some factors effecting survival in malignant gliomas. Tumori 65: 119-125. (Pubitemid 9142360)
31. Rossi, M. L., N. R. Jones, E. Candy, J. A. Nicoll, J. S. Compton, J. T. Hughes, M. M. Esiri, T. H. Moss, F. F. Cruz-Sanchez, and H. B. Coakham. 1989. The mononuclear cell infiltrate compared with survival in high-grade astrocytomas. Acta Neuropathol. 78: 189-193. (Pubitemid 19160923)
32. Safdari, H., F. H. Hochberg, and E. P. Richardson, Jr. 1979. Histological correlations with survival in malignant gliomas. Acta Neurochir. Suppl. (Wien) 28: 485-488.
33. Wrann, M., S. Bodmer, R. de Martin, C. Siepl, R. Hofer-Warbinek, K. Frei, E. Hofer, and A. Fontana. 1987. T cell suppressor factor from human glioblastoma cells is a 12.5-kd protein closely related to transforming growth factor-beta. EMBO J. 6: 1633-1636.
34. Hishii, M., T. Nitta, H. Ishida, M. Ebato, A. Kurosu, H. Yagita, K. Sato, and K. Okumura. 1995. Human glioma-derived interleukin-10 inhibits antitumor immune responses in vitro. Neurosurgery 37: 1160-1166, discussion 1166-1167.
35. Doherty, T. M., R. Kastelein, S. Menon, S. Andrade, and R. L. Coffman. 1993. Modulation of murine macrophage function by IL-13. J. Immunol. 151: 7151-7160. (Pubitemid 24001089)
36. Bettinger, I., S. Thanos, and W. Paulus. 2002. Microglia promote glioma migration. Acta Neuropathol. 103: 351-355. (Pubitemid 36097029)
37. Hussain, S. F., D. Yang, D. Suki, K. Aldape, E. Grimm, and A. B. Heimberger. 2006. The role of human glioma-infiltrating microglia/macrophages in mediating antitumor immune responses. Neuro-oncol. 8: 261-279. (Pubitemid 46542651)
38. Fecci, P. E., D. A. Mitchell, J. F. Whitesides, W. Xie, A. H. Friedman, G. E. Archer, J. E. Herndon, II, D. D. Bigner, G. Dranoff, and J. H. Sampson. 2006. Increased regulatory T-cell fraction amidst a diminished CD4 compartment explains cellular immune defects in patients with malignant glioma. Cancer Res. 66: 3294-3302.
39. Heimberger, A. B., M. Abou-Ghazal, C. Reina-Ortiz, D. S. Yang, W. Sun, W. Qiao, N. Hiraoka, and G. N. Fuller. 2008. Incidence and prognostic impact of FoxP3+ regulatory T cells in human gliomas. Clin. Cancer Res. 14: 5166-5172.
40. Sippel, T. R., J. T. White, K. Nag, V. Tsvankin, M. K. Klaassen, B. K. Kleinschmidt-Demasters, and A. Waziri. 2011. Neutrophil degranulation and immunosuppression in patients with GBM: restoration of cellular immune function by targeting arginase I. Clin. Cancer Res. 17: 6992-7002.
41. Justicia, C., C. Gabriel, and A. M. Planas. 2000. Activation of the JAK/STAT pathway following transient focal cerebral ischemia: signaling through Jak1 and Stat3 in astrocytes. Glia 30: 253-270. (Pubitemid 30259665)
42. Carro, M. S., W. K. Lim, M. J. Alvarez, R. J. Bollo, X. Zhao, E. Y. Snyder, E. P. Sulman, S. L. Anne, F. Doetsch, H. Colman, et al. 2010. The transcriptional network for mesenchymal transformation of brain tumours. Nature 463: 318-325.